Papers presented
An academic view of metals in medicine P.J. Sadler (Edinburgh, UK: Chairman COST D8) Ninety elements occur naturally on earth. Of these, 9 are radioactive, and the remaining 81 could support life; 61 are metals. It is believed that Na, Mg, K, Ca, V, Mn, Fe, Co, Ni, Cu, Zn, Mo and Sn are essential for mammalian life. On the one hand, major advances in the understanding of the biological chemistry of some of these metals have occurred over the past few years (e.g Radiopharmaceuticals and imaging agents :including the development of radionuclide complexes for diagnosis and therapy, and contrast agents for magnetic resonance imaging (MRI). This theme involves the design of ligands to control the thermodynamic and kinetic properties of metal complexes, and to achieve functional diagnosis.
Metalloproteins, enzymes and prosthetic groups this theme promotes the design of specific inhibitors of metalloenzymes, the understanding of DNA coding for metalloproteins and homeostasis, role of metals in controlling transcription, and use of coenzymes in diagnosis and therapy. Small metal complexes which mimic metalloenzymes could also find use as drugs. Speciation of metal compounds this is an important section because speciation controls the biological activity of metal ions (activity and toxicity). Studies will include those on oxidation states, types and numbers of coordinated ligands, heterogeneous media (including biof!uids, cells, tissues, and nanosurfaces), establishment of data bases. Metal-ion specific and cell-specific chelating agents offer scope not only for the treatment of metal-related diseases but also as combination agents for organic drugs.
Design and synthesis: novel compounds will be designed, for example with low toxicity, incorporating features such as ligand and metal-based chirality, unusual oxidation states, and uncommon metals. New delivery systems, slow release agents, the establishment of structureactivity relationships, as well as molecular modelling and computation, are all included in this section of the programme. 
